Stone House Investment Management, LLC Crispr Therapeutics Ag Transaction History
Stone House Investment Management, LLC
- $477 Million
- Q3 2024
A detailed history of Stone House Investment Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Stone House Investment Management, LLC holds 460 shares of CRSP stock, worth $17,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
460
Previous 526
12.55%
Holding current value
$17,779
Previous $28,000
25.0%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CRSP
# of Institutions
490Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$306 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$290 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$116 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$115 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$115 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.02B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....